Januari Fox, Director of Policy, Advocacy, and Community Engagement for Prism Health North Texas, on protecting HIV care access, advancing LGBTQ+ health equity, and why coalition-building matters in the fight for 340B. At Prism Health North Texas, Januari Fox leads policy, advocacy, and community engagement efforts focused on HIV care, prevention services, and culturally competent…
Alan Witchey, CEO of The Damien Center and member of RWC-340B, on what it takes to protect care and the coalitions making it possible At The Damien Center in Indianapolis, Alan Witchey leads one of the nation’s largest HIV/AIDS service organizations, where access to care is a daily consideration for patients with complex medical and…
As part of CV340B’s 10 Stories for 10 Years of CV340B series, we’re hearing directly from the people guiding the organization into its next decade. Rhiannon Marshall Klein has been with Community Voices for 340B since the beginning, helping build it into a unified national voice for the 340B community. Grace Shults joined the team…
“340B Gave Me Time”: A Healthcare Leader’s Personal Journey Through Cancer and Lifesaving Care My name is Jim O’Donnell, and I serve as the Executive Director of Pharmacy Services at Kettering Health in the Dayton, Ohio region. In this role, I am responsible for pharmacy services across the entire system, supported by an incredible team…
How the 340B Program Protects Rural Kentucky’s Healthcare Lifelines—and the Patients Who Depend on Them After 37 years in pharmacy, Ronnah Alexander has learned that in rural communities, small decisions can have enormous consequences. For the past nine years, she has led the 340B program at a clinic in Western Kentucky, where patients often travel…
The Lifeline of Rural Healthcare: Why Contract Pharmacies Matter in 340B Rhiannon Marshall Klein For millions of Americans, especially those in rural communities, access to affordable medications is a constant struggle. The 340B Drug Pricing Program was designed to help safety-net providers stretch scarce resources, ensuring patients receive the care they need. A critical part…
On September 30, 2024 Johnson & Johnson (J&J) announced it was ending its plans to implement a 340B rebate model for two of its drugs, Stelara and Xarelto. The immediate halt to the rebate model was prompted by the Health Resources and Services Administration’s (HRSA) September 27 letter threatening to terminate J&J’s participation in the…
In Florida, 340B helps address a common need across diverse communities: access to affordable healthcare and medications. Melissa Allen Davis, 340B Program Coordinator at Florida Community Health Centers, sees the program benefits daily in her community. At Florida Community Health Centers, letting patients know about 340B has made them more willing to engage in campaigns…
With over 30 years of experience working for non-profit health systems, Lisa Fratesi gives us a firsthand account of the 340B Program’s tremendous impact since its start, how it has evolved, the challenges 340B covered entities face today, and what her organization is doing to #Defend340B. How 340B Started In 1992, section 340B of…
Savings from the 340B program are instrumental in allowing MedStar Health to meet the ever-evolving needs of the Washington, D.C., Maryland, and Virginia metropolitan area communities. by MedStar Health July 2024 As new care needs of the community become evident, 340B savings are utilized to invest in both a pharmacy discount program to provide…